Biotech SF
San Francisco Bay Area biotech stories.
Friday, October 5, 2012
GSK returns drug to Anacor
GlaxoSmithKline has stopped work on a compound from Anacor Pharmaceuticals Inc. after finding resistance among a "small number" of patients in a mid-stage trial in complicated urinary tract infections, Palo Alto-based
Anacor said Friday
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment